ACUTE FEBRILE ENCEPHALOPATHY DIAGNOSTIC AND PROGNOSTIC DETERMINANTS
Main Article Content
Keywords
Acute febrile encephalopathy, viral meningoencephalitis, septic encephalopathy, Glasgow Coma Scale, cerebrospinal fluid analysis.
Abstract
Background: Acute febrile encephalopathy (AFE) presents a diagnostic and therapeutic challenge in the emergency department, especially in regions with diverse infectious profiles. This study aims to identify the clinical, laboratory, and radiological features of AFE and evaluate the diagnostic and prognostic determinants in a tertiary care center.
Methods: A prospective, hospital-based study was conducted at Government Medical College Srinagar from April 2021 to March 2022. All adult patients with acute febrile encephalopathy were included. Diagnostic workups included complete blood count, metabolic profile, liver function tests, chest radiography, and cerebrospinal fluid (CSF) analysis in consenting patients.
Results: A total of 91 patients (65.9% male, mean age 57.1 ± 14.91 years) were included. The most common comorbidities were hypertension (39.6%) and diabetes mellitus (29.7%). The primary presenting symptoms were fever, altered sensorium, headache (57.1%), and nuchal rigidity (41.8%). CNS infections were identified in 63.7% of cases, with viral meningoencephalitis (31.9%) being the most common etiology. Mortality was 11%, with higher rates observed in patients over 60 years (16.3%) and those with comorbidities. Mortality was significantly higher in patients with a Glasgow Coma Scale (GCS) score <10 (20.6% vs 5.3%, p<0.05). In CSF analysis, lymphocytic predominance was suggestive of viral etiology, while neutrophilic leukocytosis pointed to sepsis-associated encephalopathy.
Conclusions: CNS infections, especially viral meningoencephalitis, are the predominant cause of AFE, associated with higher mortality. Age above 60 years, hypertension, and low GCS scores were significant prognostic factors. Early lumbar puncture and timely initiation of antimicrobial therapy are essential for improving outcomes. Further studies with larger sample sizes are recommended to validate these findings.
References
2. Sheybani F, Naderi H and Sajjadi S. The optimal management of acute febrile encephalopathy in the aged patient: a systematic review. Interdisciplinary Perspectives on Infectious Diseases, 2016; Article ID 5273651.
3. Tunkel AR. Approach to the patient with central nervous system infection. In: Principles and Practice of Infectious Diseases, Bennett J, Dolin R and Blaser M, Eds., pp. 1091-1096, Elsevier, 2015.
4. Roos KL and Tyler KL. Meningitis, encephalitis, brain abscess, and empyema. In: Harrison’s Principles of Internal Medicine, D. Kasper, Ed., Mcgraw-hill, New York, 19th edition, 2015.
5. Rumboldt Z, Thurnher MM and Gupta RK. Central nervous system infections. Seminars in Roentgenology, 2007; 42(2): 62-91.
6. Bansal A, Singhi S, Singhi P, Khandelwal N, Ramesh S. Non-Traumatic coma in children. Indian J Pediatr. 2005;72:467-73.
7. Gofton T and Young G. Sepsis-associated encephalopathy. Nat Rev Neurol 2012; 8: 557-66.
8. Kennedy PGE. A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985. Q J Med 1988;68: 533-40.
9. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986; 314:144-9.
10. Whitley RJ. Viral encephalitis. N Engl J Med 1990; 323:242-50.
11. Johnston RT. Viral infections of the nervous system. 2nd Ed. Philadelphia: Lippincott-Raven, 1998.
12. Kothari VM, Karnad DR, Bichile LS. Tropical infections in the ICU. J Assoc Physicians India 2006; 54:291-8.
13. Munjal YP. API textbook of Medicine, 9th edition, Volume 2, Chapter 11, page no 1422, 2012.
14. Drive to combat Japanese Encephalitis soon. Statement by Union Health Minister, Government of India. http://timesofindia. indiatimes.com/india/Drive-to-combat-Japanese-Encephalitis-soon/ articleshow/11140076.cms. The Times of India, Dec 17, 2011.
15. Johnson RT. Acute encephalitis. Clinical Infectious Diseases, 1996;23:219-26.
16. Nicolosi A, Hauser WA, Beghi E, Kurland LT. Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950–1981. Journal of Infectious Diseases, 1986;154:399-08.
17. Davison KL, Crowcroft NS, Ramsay ME, Brown DWG, Andrews NJ. Viral encephalitis in England, 1989–1998: What did we miss? Emerging Infectious Diseases, 2003;9:234-40.
18. Hokkanen L and Launes J. Cognitive recovery instead of decline after acute encephalitis: A prospective follow up study. Journal of Neurology, Neurosurgery and Psychiatry 1997;63(2):222-27.
19. Schmolck H, Maritz E, Kletzin I, Korinthenberg R. Neurologic, neuropsychologic, and electroencephalographic findings after European tick-borne encephalitis in children. Journal of Child Neurology, 2005;20:500-508.
20. Whitley RJ and Gnann JW. Viral encephalitis: Familiar infections and emerging pathogens. Lancet, 2002;359:507-13.
21. Booss J and Esiri MM. Viral encephalitis in humans. Washington, DC: American Society for Microbiology Press, 2003.
22. McGrath N, Anderson NE, Croxson MC and Powell KF. Herpes simplex encephalitis treated with acyclovir: Diagnosis and long term outcome. Journal of Neurology, Neurosurgery and Psychiatry, 1997;63:321-26.
23. Karmarkar SA, Aneja S, Khare S, Saini A, Seth A, Chauhan BK. A study of acute febrile encephalopathy with special reference to viral etiology. The Indian Journal of Pediatrics. 2008 Aug 1;75(8):801-5.
24. Jmor F, Emsley HC, Fischer M, Solomon T, Lewthwaite P. The incidence of acute encephalitis syndrome in Western industrialised and tropical countries. Virology Journal. 2008 Oct 30;5(1):134.
25. Mailles A, Stahl JP; Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009; 49(12): 1838-47.
26. Job M, Mathuram AJ, Turaka VP, Carey RAB, Iyyadurai R, Rajan SJ. Clinical spectrum, aetiology and predictors of acute febrile encephalopathy at a tertiary hospital in south India- A prospective observational study. Tropical Doctor 2021; 51(1): 58-64.
27. Sajadi S and Naderi H. Acute Febrile Encephalopathy in Adults: A Review of Three Prospective Trials. Patient Saf Qual Improv. 2017; 5(2):548-552.
28. Peidaee E, Sheybani F, Naderi HR, Khosravi N, Nooghabi MJ. The Etiological Spectrum of Febrile Encephalopathy in Adult Patients: A Cross-Sectional Study from a Developing Country. Hindawi Emergency Medicine International. Volume 2018, Article ID 3587014, 8p https:// doi.org/ 10.1155/ 2018/3587014.
29. Singh Y, Satyawali V, Kumar J, Saxena SR. Acute febrile encephalopathy: an experience from tertiary care centre. Annals of International Medical and Dental Research, 2017; 3(5): 28-32.
30. Sen I, Bhattacharya S, Bhakta S, Ranjan S. A study on etiological profile in adults with acute febrile encephalopathy in a tertiary care centre in eastern India. International Journal of Medical and Biomedical Studies, 2019; 3(3). DOI: https://doi.org/10.32553/ijmbs.v3i3.132.
31. Bhalla A, Suri V, Varma S, Sharma N, Mahi S, Singh P, Khandelwal NK. Acute febrile encephalopathy in adults from Northwest India. J Emerg Trauma Shock. 2010; 3(3): 220-4.
32. Clare Huppatz, David N. Durrheim et al. Etiology of Encephalitis in Australia, 1990–2007. Emerging Infectious Diseases. 2009; 15(9):www.cdc.gov/eid.
33. Khan R, Quaiser S, Alam S. Clinical profile and prognostic markers of acute febrile encephalopathy (AFE) in adult patients presenting to a North Indian tertiary care hospital. Int J Nutr Pharmacol Neurol Dis 2015;5:95-102.
34. Biswas R, Basu K, Tripathi I, Roy SK. A study on etiology, clinical profile and outcome of acute febrile encephalopathy in children: A prospective study at a tertiary care center of Eastern India. Asian Journal of Medical Sciences 2021; 12(4): 86-91.